YSC1
Yeast from Saccharomyces cerevisiae
Type I
Synonym(s):
(Bakers yeast)
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
UNSPSC Code:
12352202
NACRES:
NA.81
Recommended Products
biological source
Saccharomyces cerevisiae
type
Type I
form
powder or solid
application(s)
food and beverages
microbiology
storage temp.
2-8°C
General description
Yeast from Saccharomyces cerevisiae (Baker′s yeast) is the oldest microbial starter. It is a facultative anaerobe.
Application
Yeast from Saccharomyces cerevisiae has been used:
- as a biocatalyst for the anode of yeast microbial fuel cell
- for the production of ethanol for fuel use
- to prepare yeast extract
Biochem/physiol Actions
Yeast from Saccharomyces cerevisiae (Baker′s yeast) is used as a protein supplement, energy booster and immune enhancer. It serves as a dough leavening agent in bread production by converting the fermentable sugars to CO2 and ethanol. Baker′s yeast exhibits aroma, anti-molding and nutritive properties. It acts as a cell factory.
Caution
Autolyzes in aqueous buffer at 37 °C.
Preparation Note
Dried to avoid inactivation of enzymes.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Electrostatically enhanced performance of a yeast-based microbial fuel cell
Song Y, et al.
Royal Society of Chemistry Advances, 5(25), 19203-19205 (2015)
Brewer's/baker's yeast (Saccharomyces cerevisiae) and preventive medicine: Part II
Moyad MA
Urologic Nursing, 28(1), 73-75 (2008)
Laura C Swanson et al.
G3 (Bethesda, Md.), 10(9), 3109-3119 (2020-07-08)
Neuroinflammation is a major pathophysiological feature of traumatic brain injury (TBI). Early and persistent activation of innate immune response signaling pathways by primary injuries is associated with secondary cellular injuries that cause TBI outcomes to change over time. We used
Laura C Swanson et al.
Genetics, 216(4), 1117-1136 (2020-10-29)
Traumatic brain injury (TBI) pathologies are caused by primary and secondary injuries. Primary injuries result from physical damage to the brain, and secondary injuries arise from cellular responses to primary injuries. A characteristic cellular response is sustained activation of inflammatory
Laboratory Manual In Microbiology (2007)
Protocols
This procedure may be used for the determination of Lyticase activity using Baker’s yeast as the substrate.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service